Epstein-Barr virus: a paradigm for persistent infection - for real and in virtual reality

scientific article published on 06 March 2008

Epstein-Barr virus: a paradigm for persistent infection - for real and in virtual reality is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.IT.2008.01.006
P698PubMed publication ID18328785

P2093author name stringDavid A Thorley-Lawson
Michael Shapiro
Karen A Duca
P2860cites workAnti-apoptotic function of a microRNA encoded by the HSV-1 latency-associated transcriptQ28243242
P433issue4
P921main subjectEpstein–Barr virusQ6900
virtual realityQ170519
P304page(s)195-201
P577publication date2008-03-06
P13046publication type of scholarly workreview articleQ7318358
P1433published inTrends in ImmunologyQ15265730
P1476titleEpstein-Barr virus: a paradigm for persistent infection - for real and in virtual reality
P478volume29

Reverse relations

cites work (P2860)
Q42578310A model of host response to a multi-stage pathogen
Q36700342Analysis of Epstein-Barr virus infection models in a series of pediatric carriers from a developing country
Q34211180Autoimmune disease: A role for new anti-viral therapies?
Q33735916Characterization of Epstein Barr virus latency pattern in Argentine breast carcinoma
Q38822525Childhood, adolescent and young adult non-Hodgkin lymphoma: state of the science
Q35463816Comparison of humoral immune responses to Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus using a viral proteome microarray
Q40085350Consideration of Epstein-Barr Virus-Encoded Noncoding RNAs EBER1 and EBER2 as a Functional Backup of Viral Oncoprotein Latent Membrane Protein 1.
Q42123554Constitutive Interferon-Inducible Protein 16-Inflammasome Activation during Epstein-Barr Virus Latency I, II, and III in B and Epithelial Cells
Q36137341Epstein-Barr Virus IL-10 Engages IL-10R1 by a Two-step Mechanism Leading to Altered Signaling Properties
Q38833567Epstein-Barr Virus-Positive Posttransplant Lymphoproliferative Disease After Solid Organ Transplantation: Pathogenesis, Clinical Manifestations, Diagnosis, and Management
Q26998999Epstein-Barr virus and the origin of Hodgkin lymphoma
Q35115666Epstein-Barr virus type 2 latently infects T cells, inducing an atypical activation characterized by expression of lymphotactic cytokines.
Q42214818Epstein-Barr virus, the germinal centre and the development of Hodgkin's lymphoma
Q38968588Epstein-Barr virus: more than 50 years old and still providing surprises.
Q36625981Epstein–Barr virus‐induced epigenetic alterations following transient infection
Q89783184Herpesviral Latency-Common Themes
Q38032237Herpesviral infection and Toll-like receptor 2
Q38778924Immunotherapy against cancer-related viruses
Q42702857Innate immune modulation in EBV infection
Q38186778Is murine gammaherpesvirus-68 (MHV-68) a suitable immunotoxicological model for examining immunomodulatory drug-associated viral recrudescence?
Q37192117Laboratory assays for Epstein-Barr virus-related disease
Q35641151Maintenance of Epstein-Barr Virus Latent Status by a Novel Mechanism, Latent Membrane Protein 1-Induced Interleukin-32, via the Protein Kinase Cδ Pathway.
Q37827143Pathogenesis and Host Control of Gammaherpesviruses: Lessons from the Mouse
Q93079245Sneaking Out for Happy Hour: Yeast-Based Approaches to Explore and Modulate Immune Response and Immune Evasion
Q38026758T-cell therapy in the treatment of post-transplant lymphoproliferative disease
Q34712750Tegument protein control of latent herpesvirus establishment and animation
Q38258049The Epstein-Barr virus and the pathogenesis of lymphoma.
Q35140290Transforming growth factor beta-induced reactivation of Epstein-Barr virus involves multiple Smad-binding elements cooperatively activating expression of the latent-lytic switch BZLF1 gene.
Q34039189Viral latency and its regulation: lessons from the gamma-herpesviruses

Search more.